729
Views
56
CrossRef citations to date
0
Altmetric
Review

Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

, , , &
Pages 435-448 | Published online: 11 Jun 2012

Abstract

Diabetes mellitus (DM) is a pandemic and chronic metabolic disorder with substantial morbidity and mortality. In addition, osteoporosis (OP) is a silent disease with a harmful impact on morbidity and mortality. Therefore, this systematic review focuses on the relationship between OP and type 2 diabetes mellitus (T2DM). Systematic reviews of full-length articles published in English from January 1950 to October 2010 were identified in PubMed and other available electronic databases on the Universiti Sains Malaysia Library Database. The following keywords were used for the search: T2DM, OP, bone mass, skeletal. Studies of more than 50 patients with T2DM were included. Forty-seven studies were identified. The majority of articles (26) showed increased bone mineral density (BMD), while 13 articles revealed decreased BMD; moreover, eight articles revealed normal or no difference in bone mass. There were conflicting results concerning the influence of T2DM on BMD in association with gender, glycemic control, and body mass index. However, patients with T2DM display an increased fracture risk despite a higher BMD, which is mainly attributable to the increased risk of falling. As a conclusion, screening, identification, and prevention of potential risk factors for OP in T2DM patients are crucial and important in terms of preserving a good quality of life in diabetic patients and decreasing the risk of fracture. Patients with T2DM may additionally benefit from early visual assessment, regular exercise to improve muscle strength and balance, and specific measures for preventing falls. Patient education about an adequate calcium and vitamin D intake and regular exercise is important for improving muscle strength and balance. Furthermore, adequate glycemic control and the prevention of diabetic complications are the starting point of therapy in diabetic patients.

Introduction

Diabetes mellitus (DM) is a chronic metabolic disorder with substantial morbidity and mortality, characterized by the presence of hyperglycemia.Citation1,Citation2 Pharmacotherapy, continuing medical care, and education are crucial for preventing acute and chronic complications. On the other hand, osteoporosis (OP) is a painless weakening of the bones that constitutes an enormous socioeconomic crisis, with a harmful impact on morbidity and mortality.Citation3,Citation4 It leads to increased skeletal fragility and microarchitectural deterioration of bone tissue, causing a decrease in bone mineral density (BMD), bone quality, and strength.Citation5,Citation6 Osteoporosis can result in height loss, severe back pain, deformity, impairments in a person’s ability to walk, disability, and even death.Citation7,Citation8

Moreover, OP has been considered to be a disorder of postmenopausal white women; several studies investigating BMD and fracture risk in women of different ethnicities have revealed conflicting evidence regarding osteoporosis risk.Citation9 In addition, white women have higher hip fracture rates than black, Asian, and Hispanic women.Citation10Citation12 Similarly, many results have indicated that Hispanic women are at higher risk for developing OP than non–Hispanic white women.Citation13Citation15

Along with an increased risk of complications, including retinopathy, nephropathy, neuropathy, and cardiovascular events, there is strong evidence for reduced BMD in children, adolescents, and adults with type 1 diabetes mellitus (T1DM),Citation16Citation23 which might reduce the peak bone mass attained and increase the risk of osteoporosis and its related complications in later life.Citation24,Citation25 Though the relationship between T2DM and osteoporosis has been widely investigated, it remains controversial. Diabetes could influence bone through several mechanisms, some of which may have contradictory effects. Obesity, widespread in T2DM, is strongly associated with higher BMD, probably through mechanical loading and hormonal factors, including insulin, estrogen, and leptin.Citation26Citation28 Hyperinsulinemia may promote bone formation.Citation29 Therefore, low levels of insulin and the progression of T2DM may cause reductions in BMD. Higher glucose levels in the blood are known to interact with several proteins to generate a higher concentration of advanced glycation end-products (AGEs) in collagen that may reduce bone strength.Citation30 Yamagishi et al hypothesized that AGEs in collagen may interact with bone to reduce bone strength, resulting in osteoporosis in patients with diabetes.Citation31 Accumulated AGEs in the body may stimulate apoptosis of osteoblasts, thereby contributing to deficient bone formation.Citation32 Another indirect effect of hyperglycemia is glycosuria, which causes hypercalciuria, leading to decreased levels of calcium in the body and poor bone quality, hastening bone loss.Citation33,Citation34 There is established evidence that low levels of vitamin D are not only associated with the incidence of DM but also that altered vitamin D metabolism leads to diabetic osteopenia.Citation35,Citation36

In addition, microvascular complications of diabetes lead to reduced blood flow to bone and may contribute to bone loss and fragility.Citation37,Citation38 Additional studies are required to determine whether DM is a leading cause of the development of osteoporosis or whether osteoporosis is aggravated by the presence of DM and should be considered as one of the long-term complications of diabetes.Citation39Citation44 Thus, identifying and evaluating populations at increased risk of developing osteoporosis is critical in disease prevention and management.

In 1948, Albright and Reifenstein reported a loss of bone mass leading to osteoporosis in diabetic patients with poor glycemic control.Citation45 Many clinical studies have reported that osteoporosis is one of the chronic complications associated with DM. These findings have received a great deal of attention and have been investigated by a number of researchers.Citation46Citation48 Osteoporosis is a prevalent metabolic bone disease worldwide,Citation49,Citation50 and its occurrence in patients who have diabetes further increases their burden of disease. BMD is often used as an indication of susceptibility to osteoporosis. Bone mass is determined by the measure of peak bone mass, which attains a maximum in the second decade of life and starts to decrease after the third decade of life.Citation51Citation53 Therefore, early BMD tests are very important. In order to define osteoporosis, a group of experts convened by the World Health Organization divided BMD T-scores into the three following categories: “normal (T-score of -1.0 or higher), osteopenia (T-score between –1.0 and –2.5), or osteoporosis (T-score ≤ –2.5).”Citation54 In addition to the diagnostic tools for osteoporosis (BMD test), Cummings et al suggested that it would be more sensible to focus on the risk of fracture based on a combination of factors, rather than solely relying on the diagnostic labels obtained from a T-score, since fracture risk factors are independent of BMD.Citation55 For example, a woman who has a vertebral fracture has a fourfold increase in risk of another vertebral fracture regardless (or independent) of her BMD.Citation56,Citation57

Risk factors that predict hip fracture independently of BMD include age, personal history of fracture, parental history of hip fracture,Citation58,Citation59 current cigarette smoking,Citation60Citation62 low body weight,Citation63 poor health, low calcium intake, low level of vitamin D, alcoholism, inadequate physical activity, and use of (or plans to use) oral corticosteroids for longer than 3 months,Citation64 or serious long-term conditions thought to increase fracture risk and the risk of falling, such as hyperthyroidism, hypogonadism, diabetes mellitus, rheumatoid arthritis, malabsorption,Citation65,Citation66 increased levels of markers of bone resorption,Citation67 and very low serum levels of estradiol.Citation68

Methods

Systematic reviews of full-length articles published in English from January 1950 to October 2010 were identified in PubMed, Medline, Inside Web, ISI Web of Knowledge, Science Direct, Springer Link, Ebsco Host, and other available electronic databases at Universiti Sains Malaysia Library. The following keywords were used in the search: type 2 diabetes mellitus, osteoporosis, bone, skeletal, BMD, dual X-ray absorptiometry (DXA), and quantitative ultrasound scan (QUS). More than 70 articles were identified, and those judged to be relevant by the authors were further evaluated. Clinical studies that included BMD measurements in patients with T2DM were extended to those using DXA and other methods. For studies that investigated BMD in T2DM, only studies that included more than 50 patients were reviewed.

Results and discussion

Key findings

Forty-seven studies were identified: seven were from the US, six from Japan, four each from Turkey, Iran, and Italy, three from China, two each from Spain, the UK, Saudi Arabia, Kuwait, and Netherlands, and one each from Denmark, Greece, Sweden, Croatia, Canada, Norway, Egypt, Korea, and Finland. In general, most of the studies showed controversy over the effect of diabetes on bone mass in T2DM. The majority of articles (26) showed increased BMD, while 13 articles revealed decreased BMD; moreover, eight articles revealed normal or no difference bone mass, as shown in .

Table 1 Osteoporosis in type 2 diabetes mellitus

Osteoporosis in diabetes mellitus type 2

Diabetes has burdened the health-care system, which is already under strain due to other chronic diseases. Uncontrolled diabetes has led to an increase in the rate of complications, and thus has doubled the cost of treating these patients.Citation69,Citation70 It has long been known that the alterations in bone and mineral metabolism are clinically complicated in patients with DM.Citation39,Citation71 Although osteopenia is an established complication of T1DM, particularly in patients with poor control who have been treated with large doses of insulin,Citation72 contradictory results have been found for patients with T2DM.Citation73,Citation74 In addition, there have been conflicting observations concerning the incidence of osteoporosis depending on differences in sex, age, and race or the methods used to detect the increase or decrease in BMD.Citation33,Citation75 In fact, a reduction in bone mineral content has been observed in both T1DM and T2DM patients.Citation43,Citation76

For patients with T2DM, some authors have reported an elevated BMD,Citation75,Citation77Citation81 other studies have reported a decreased BMD,Citation33,Citation43,Citation74,Citation76 and some have reported unaltered bone density,Citation28,Citation73,Citation82; some cross-sectional studies have even found normal BMD.Citation83Citation85 Several mechanisms have been proposed for diabetes-related osteoporosis. These include both the comorbidities of diabetes and more direct pathophysiological effects of the disease itself.Citation86Citation88

Fractures and diabetes mellitus type 2

The incidence of fracture was reported to be lower in T2DM patients compared to nondiabetic controls in someCitation75,Citation89 but not all studies.Citation90,Citation91 In addition, the relationship between fracture and T2DM is less clear, because many factors have an effect, such as an increase in BMD and different study designs, ages, body mass index (BMI), race, and gender, which all contribute to the conflicting results. In a study of nearly 1000 diabetic subjects, Heath and co-workers found decreased fracture rates in men and women with diabetes compared to the fracture incidence in the nondiabetic population, but they were unable to adjust for obesity, which is positively associated with T2DM and inversely associated with osteopenia.Citation92 This was in contrast to the results of other studies, which was surprising given the increased fracture risk associated with T2DM.Citation93,Citation94 A similar study found that whilst women with T2DM had a significant risk of hip fractures, this was much lower than for the women with T1DM.Citation95,Citation96

On the other hand, T2DM was previously believed to be associated with normal to increased BMD, which may be considered as an osteoprotective effect. These reports were based on the concept of BMD alone and not from prospective controlled large trials. Moreover, BMD measurement in predicting osteoporotic fractures may be limited by two main factors: decreased bone quality (which cannot be measured by DXA) and a higher risk of falls. Bone quality changes may also be affected by microvascular events common in diabetes.Citation38 Patients with T2DM generally have an increased risk of falling because of peripheral neuropathy, possible hypoglycemia, nocturia, and visual impairment. In addition, many type 2 diabetic patients are obese and sedentary; coordination and balance factors that are protective in falls may be absent. Thus, patients with generally larger body size and relatively high bone mass may have higher fracture rates. Therefore, normal BMD values may be misleading. A large prospective study of older women obtained from the Study of Osteoporotic Fractures confirmed that women with type 2 diabetes experience higher fracture rates in regions of the hip, humerus, and foot than do nondiabetic women.Citation93

Osteoporosis and gender

Several studies found that people with T2DM have increased, normal, decreased, or no difference in bone mass compared to healthy control subjects.Citation82Citation84,Citation97 On the other hand, the problem of osteoporosis in men has been overlooked in the past.Citation98 Although not as common as in women, hip and spine fractures in men are associated with higher morbidity and mortality than in women,Citation99 and the prevalence of vertebral fractures in men is similar to or even higher than that in women.Citation100,Citation101

Three studies investigated the decrease in bone mass in men; two studies were performed using computed X-ray densitometry at the metacarpus bone in 151 and 104 male T2DM patients aged 55.Citation44,Citation102 The third study assessed BMD measured by DXA in 131 elderly T2DM males in China. The findings from this study also suggested that decreased BMD and poor glycemic control were correlated with osteoporosis.Citation103 In contrast, Bridges et al assessed the BMD in 35 and 90 men with T1DM and T2DM, respectively, compared to 50 control subjects. This study found no difference between bone mass and diabetic status. In addition, no correlation was found between BMD and the glycosylated hemoglobin concentration, disease duration or the presence of microvascular or macrovascular complications in either of the diabetic groups.Citation104

On the other hand, three studies reported a lower incidence of osteopenia and increased bone mass in older women with diabetes. In 1967, Meema and Meema reported a significantly increased cortical thickness of the radial bone in 63 elderly women with diabetes compared to 133 women without diabetes. This difference persisted after adjusting for body weight, and the authors postulated that diabetes was an “antiosteoporotic condition.”Citation78

In 1985, Johnston and colleagues reported a significantly greater mid-radial bone mass in 79 postmenopausal women with T2DM (68% of whom were being treated with insulin) compared to 59 in the control group. The calculated rate of bone loss was about half that expected and was not explained by obesity.Citation79 In 1989, Weinstock et al reported a nonsignificantly higher BMD in 28 T2DM women with mean age of 59 years compared to 207 age-matched volunteers.Citation73 Thus, women with T2DM are not at an increased risk of diminished BMD, and may even be protected against bone loss. Relatively little attention has been paid to these remarkable findings. Since these studies were limited to women, sex differences were not described, and also the sample size was small. A similar finding was reported for 47 elderly T2DM women where the BMD was measured using two different methods (DXA and quantitative computed tomography), where no evidence was found to show that T2DM produces any change in bone metabolism or mass.Citation84 Moreover, a population-based family study of Mexican Americans (600 subjects from 34 families) confirmed that diabetic women aged 55 years have a higher BMD compared to their nondiabetic counterparts.Citation46 In addition, two studies assessed the association of T2DM with BMD in older patients (aged ≥55 years), and both studies found an increase in BMD.Citation75,Citation89 In one population-based Rotterdam Study with a sample size of 5931, it was shown that both men and women with T2DM had an increased BMD, and that in women this was associated with a lower frequency of nonvertebral fractures.Citation89 A similar finding related to increased BMD found in white diabetic women, whereas no differences in bone density according to diabetic status were observed in men, and the sex differences were explained by the greater androgenicity reported in women with hyperglycemic and hyperinsulinemic conditions.Citation75

On the other hand, menopause is one of the most important risk factors for osteoporosis in women and is characterized by rapid bone loss in newly postmenopausal women. The loss of BMD is accelerated after the cessation of ovarian secretions,Citation105,Citation106 and estrogen deficiency is an important factor causing osteoclast activation.Citation107 In our survey of the scientific literature related to the association between T2DM and bone mass, we identified 16 studies out of 47 that assessed bone mass in postmenopausal T2DM; the majority (13) of studies showed increased BMD and lower osteoporosis risk, whereas two studies showed decreased BMDCitation108,Citation109 and one study showed no difference in BMD when compared with normal subjects,Citation110 as shown in .

Osteoporosis and glycemic control

Most of the studies were performed on T2DM patients under fairly controlled and stable conditions; in one of these studies, the mean glycosylated hemoglobin was 6.7%.Citation75 Therefore, it is as yet unknown whether changes in glycemic control influence bone turnover in T2DM patients, although some papers have reported that BMD decreased more severely in patients with poorly controlled type 2 diabetes.Citation33,Citation111 In 1997, one study assessed BMD before and after glycemic control for 3 weeks in 78 patients with poorly controlled T2DM (age 28–73 years) with an initial glycosylated hemoglobin level of more than 8%, and found that metabolic improvements in poorly controlled T2DM decreased bone loss within a short period. Thus, glycemic control might protect T2DM patients from bone loss.Citation112 On the other hand, some studies have reported that insulin level has a vital effect on bone mass.Citation113Citation117 Japanese T2DMs have the clinical feature of low insulin secretion, which may predispose them to the risk of lower BMD.Citation118,Citation119 In 2005, Majima et al assessed the association between T2DM, BMD, metabolic control, and insulin-secretion capacity in 145 elderly Japanese diabetic patients compared to 95 subjects in the control group who were of a similar age. This study indicated that there was loss in cortical bone and positive correlation between the levels of insulin secretion and BMD at different sites (lumbar spine, femoral neck, distal radius); in addition, maintaining good metabolic control was key in preventing bone loss in T2DM.Citation117 In contrast, Oz et al, in 2006, found an association between T2DM and higher BMD in 52 diabetic men and women aged 41–64 years compared to 48 nondiabetic control subjects. These findings suggest that although bone mass formation is lower in T2DM, diabetic patients are not susceptible to bone resorption. This low bone turnover can slow the rate of bone loss and cause a higher BMD than would be expected for a certain age.Citation120

Osteoporosis and body mass index

Another important factor that affects BMD and confuses findings is the BMI, in addition to heredity, nutritional dietary customs, height, and lean mass.Citation121,Citation122 A low BMI is associated with decreased BMD, the increased possibility of osteoporosis, and the risk of fracture.Citation123 A meta-analysis demonstrated that BMI is also an important predictor of BMD in T2DM.Citation124 Overweight and obesity are believed to be protective factors of BMD.Citation125,Citation126 Compared with Caucasian populations, diabetic women in Asia are relatively shorter, a lower percentage are overweight, and they have a lower insulin sensitivity.Citation127,Citation128 Furthermore, BMI is a powerful and modifiable risk factor for both DM and OP.Citation129,Citation130 However, the impact of BMI with racial/ethnic disparities in overweight and obesity (measured by BMI) is well documented in many studies.Citation131,Citation132 BMI disparities are more pronounced and consistent among women,Citation133,Citation134 age,Citation135 education,Citation136 existence of morbid conditions,Citation137 and marital status.Citation136 Seo and Torabi examined the effect of race/ethnicity on BMI among US adults by gender, adjusting the effects of age, education, serious morbidity, and marital status. There was no evidence of decrease in the prevalence of overweight or BMI and diabetes among US adults.Citation138

However, in Western countries, a BMI ≥27 kg/m2 is often used to define obesity. Using this definition, 33% of US adults are considered to be overweight,Citation139 while in Hong Kong Chinese of working age, only 11.6% have a BMI ≥ 27 kg/m2.Citation140 If BMI ≥ 30 kg/m2 is used to define obesity, 8%–15% of CaucasiansCitation141,Citation142 but only 2.2%–4.8% of Hong Kong Chinese will be considered to be obese.Citation140 Similarly, the mean BMI in UK subjects is 26.0 kg/m2 for men and 26.3 kg/m2 for women.Citation143 This is compared to 23.4 kg/m2 and 23.3 kg/m2 in Hong Kong Chinese men and women, respectively. In addition, Asians, although mean BMI is lower, have a higher percentage body fat and more upper-body subcutaneous fat.Citation127 A recent study of more than 13,000 Chinese men and women with significantly lower mean BMI (21 kg/m2) found the percentage body fat was inversely related to BMD as measured by DXA at the spine, hip, and total body.Citation144 In a meta-analysis that included data for three Asian groups, Deurenberg et al found that the percentage body fat was higher than predicted at low BMI levels for Chinese. Body fat was underestimated across all BMI levels for Thais and Indonesians.Citation145 In a similar study of women in Hawaii, Novotny et al found that Asian women had a greater percentage of body fat than did white women with the same BMI.Citation146 The limited data concerning the correlation between BMI and adiposity suggest that health effects of BMI may differ as US-born Asian Americans are significantly more likely to be obese or overweight than the foreign-born Asian Americans.Citation127 These conflicting results suggest a complex relationship between fat mass and bone mass is likely depending on the patient’s age, sex and ethnicity.Citation147 To date, relatively few studies have examined this relationship.Citation148

Conclusion

With progressive aging of the population, there will be a huge increase in the prevalence of osteoporosis, which is considered to be one of the most common public health problems in the world. However, the impact of diabetes disease on osteoporosis has not yet been carefully considered. Therefore, there is a need for further longitudinal studies, including the incidence and risk factors for osteoporotic fractures. In clinical routine, the extent of diagnostic and therapeutic activities in patients with T2DM in respect to generalized bone disease or diabetic osteopenia should be based on individual conditions and risk profile for osteoporosis. In addition, osteoprotective behavior must be assessed, as low educational levels about OP may put those populations at high risk of fractures. Therefore, patient education needs to highlight that weight-bearing exercise and consuming calcium-rich foods not only prevent osteoporosis but also can decrease BMI, reduce blood pressure, and improve lipid and diabetic control, which are often significant risk comorbidities in diabetic patients. Therefore, the routine screening of risk factors and patient education about bone density evaluation are important and should be recommended to all diabetic patients. Also, all patients with diabetes, and particularly those with high risk of fractures, should be given general information regarding proper home-safety measures to reduce risk of falling, including the wearing of hip protectors, especially in the elderly. Future studies need to be prospective, controlled with large sample sizes, and include evaluations of bone quality at different sites (not just bone size), BMI, the duration of diabetes, race, glycemic control, fractures, complications, and BMD, in order to identify the possible relationship between diabetes and osteoporosis.

Acknowledgment

SA Abdulameer gratefully acknowledges the Universiti Sains Malaysia, Penang, Malaysia, for granting her the USM Postgraduate Student Fellowship.

Disclosure

The authors report no conflicts of interest in this work.

References

  • RodbardHWBlondeLBraithwaiteSSAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitusEndocr Pract20071316817613449
  • RoglicGUnwinNBennettPHThe burden of mortality attributable to diabetesDiabetes Care20052892130213516123478
  • HadjidakisDMylonakisASfakianakisMRaptisARaptisSDiabetes and premature menopause: is their co-existence detrimental to the skeleton?Eur J Endocrinol2005152343744215757861
  • ReyesBMorenoOPrevalence of osteopenia and osteoporosis in postmenopausal womenAten Primaria2005357342347 Spanish15871793
  • CooperCMeltonL3rdEpidemiology of osteoporosisTrends Endocrinol Metab19923622422918407104
  • NewSBone health: the role of micronutrientsBr Med Bull199955361963310746351
  • HeinemannDOsteoporosis. An overview of the National Osteoporosis Foundation clinical practice guideGeriatrics2000555313610826263
  • SalkeldGCameronICummingRQuality of life related to fear of falling and hip fracture in older women: a time trade off studyBMJ2000320723134134610657327
  • BabbarRHandaALoCBone health of immigrant Chinese women living in New York CityJ Community Health200631172316482763
  • PollitzerWSAndersonJJEthnic and genetic differences in bone mass: a review with a hereditary vs environmental perspectiveAm J Clin Nutr1989506124412592688394
  • SilvermanSLMadisonREDecreased incidence of hip fracture in Hispanics, Asians, and blacks: California Hospital Discharge DataAm J Public Health19887811148214833177728
  • RossPDNorimatsuHDavisJWA comparison of hip fracture incidence among native Japanese, Japanese Americans, and American CaucasiansAm J Epidemiol199113388018092021147
  • SirisESChenYTAbbottTABone mineral density thresholds for pharmacological intervention to prevent fracturesArch Intern Med2004164101108111215159268
  • SirisEMillerPBarrett-ConnorEAbbottTSherwoodLBergerMDesign of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal womenOsteoporos Int19988S62699682801
  • SirisESMillerPDBarrett-ConnorEIdentification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal womenJAMA2001286222815282211735756
  • LettgenBHauffaBMöhlmannCJekenCReinersCBone mineral density in children and adolescents with juvenile diabetes: selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomographyHorm Res19954351731757782045
  • GunczlerPLanesRPaz-MartinezVDecreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinallyJ Pediatr Endocrinol Metab199811341341911517957
  • ErsoyBGökenDDarcanSMaviEÖztürkCEvaluation of bone mineral density in children with diabetes mellitusIndian J Pediatr199966337537910798085
  • HoughFAlterations of bone and mineral metabolism in diabetes mellitus. II: Clinical studies in 206 patients with type I diabetes mellitusSAMJ S Afr Med J1987722120126
  • LeonMLarroderaLLledoGHawkinsFStudy of bone loss in diabetes mellitus type 1Diabetes Res Clin Pract1989632372422785908
  • WiskePWentworthSNortonJJrEpsteinSJohnstonCJrEvaluation of bone mass and growth in young diabeticsMetabolism19823188488546980356
  • AuwerxJDequekerJBouillonRGeusensPNijsJMineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitusDiabetes19883718123335279
  • ForstTBeyerJPfütznerAPeripheral osteopenia in adult patients with insulin-dependent diabetes mellitusDiabet Med199512108748798846677
  • NevittMJohnellOBlackDEnsrudKGenantHCummingsSBone mineral density predicts non-spine fractures in very elderly womenOsteoporos Int1994463253317696827
  • MeltonL3rdAtkinsonEO’FallonWWahnerHRiggsBLong-term fracture prediction by bone mineral assessed at different skeletal sitesJ Bone Miner Res1993810122712338256660
  • FelsonDTZhangYHannanMTAndersonJJEffects of weight and body mass index on bone mineral density in men and women: the Framingham studyJ Bone Miner Res1993855675738511983
  • ThomasTBurgueraBMeltonLJRole of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus womenBone200129211412011502471
  • WakasugiMWakaoRTawataMGanNKoizumiKOnayaTBone mineral density measured by dual energy X–ray absorptiometry in patients with non-insulin-dependent diabetes mellitusBone199314129338442999
  • ReidIEvansMCooperGAmesRWStapletonJCirculating insulin levels are related to bone density in normal postmenopausal womenAm J Physiol Endocrinol Metab19932654E655659
  • PaulRBaileyAGlycation of collagen: the basis of its central role in the late complications of ageing and diabetesInt J Biochem Cell Biol19962812129713109022289
  • YamagishiSNakamuraKInoueHPossible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patientsMed Hypotheses20056561013101516146671
  • AlikhaniMAlikhaniZBoydCAdvanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathwaysBone200740234535317064973
  • GregorioFCristalliniSSanteusanioFFilipponiPFumelliPOsteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?Diabetes Res Clin Pract199423143548013262
  • RaskinPStevensonMRMBarillaDEPakCYCThe hypercalciuria of diabetes mellitus: its amelioration with insulinClin Endocrinol (Oxf)197894329335214258
  • IshidaHSeinoYMatsukuraSDiabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetesMetabolism19853497978014033421
  • PittasAGLauJHuFBDawson-HughesBThe role of vitamin D and calcium in type 2 diabetes. a systematic review and meta-analysisJ Clin Endocrinol Metab20079262017202917389701
  • WientroubSEisenbergDTardimanRWeissmanSSalamaRIs diabetic osteoporosis due to microangiopathy?Lancet1980282019836107626
  • VogtMTCauleyJAKullerLHNevittMCBone mineral density and blood flow to the lower extremities: the study of osteoporotic fracturesJ Bone Miner Res19971222832899041062
  • PiepkornBKannPForstTAndreasJPfutznerABeyerJBone mineral density and bone metabolism in diabetes mellitusHorm Metab Res199729115845919479561
  • Leidig-BrucknerGZieglerRDiabetes mellitus: a risk for osteoporosis?Exp Clin Endocrinol Diabetes2001109493514
  • SchwartzADiabetes mellitus: does it affect bone?Calcif Tissue Int200373651551914517715
  • ThrailkillKLumpkinCJrBunnRKempSFowlkesJIs insulin an anabolic agent in bone? Dissecting the diabetic bone for cluesAm J Physiol Endocrinol Metab20052895E73574516215165
  • LevinMBoisseauVAvioliLEffects of diabetes mellitus on bone mass in juvenile and adult-onset diabetesN Engl J Med197629452412451244549
  • SuzukiKSugimotoCTakizawaMCorrelations between bone mineral density and circulating bone metabolic markers in diabetic patientsDiabetes Res Clin Pract200048318519110802157
  • AlbrightFReifensteinEBone development in diabetic children: a roentgen studyAm J Med Sci1948174313319
  • KaoWHKammererCSchneiderJBauerRMitchellBType 2 diabetes is associated with increased bone mineral density in Mexican-American womenArch Med Res200334539940614602507
  • KayathMDibSVieiraJPrevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitusJ Diabetes Complicat199482971048061353
  • ChristensenJSvendsenOBone mineral in pre and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitusOsteoporos Int199910430731110692980
  • PhillipsPBraddonJOsteoporosis – diagnosis, treatment and managementAust Fam Physician200433311112015054973
  • ZylstraRPorterLShapiroJPraterCPrevalence of osteoporosis in community-dwelling individuals with intellectual and/or developmental disabilitiesJ Am Med Dir Assoc20089210911318261703
  • BonjourJChevalleyTRizzoliRFerrariSGene-environment interactions in the skeletal response to nutrition and exercise during growthMed Sport Sci200751(R)648017505120
  • HenryYFatayerjiDEastellRAttainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral densityOsteoporos Int200415426327314985946
  • WeaverCThe role of nutrition on optimizing peak bone massAsia Pac J Clin Nutr200817Suppl 113513718296321
  • GenantHKCooperCPoorGInterim report and recommendations of the World Health Organization Task-Force for OsteoporosisOsteoporos Int199910425926410692972
  • CummingsSBatesDBlackDClinical use of bone densitometry: scientific reviewJAMA2002288151889189712377088
  • RossPDDavisJWEpsteinRSWasnichRDPre-existing fractures and bone mass predict vertebral fracture incidence in womenAnn Intern Med1991114119199232024857
  • BlackDMArdenNKPalermoLPearsonJCummingsSRPrevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fracturesJ Bone Miner Res199914582182810320531
  • KlotzbuecherCMRossPDLandsmanPBAbbottTA3rdBergerMPatients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesisJ Bone Miner Res200015472173910780864
  • BurgerHDe LaetCWeelAHofmanAPolsHAdded value of bone mineral density in hip fracture risk scoresBone199925336937410495142
  • FowkesFAetiology of peripheral atherosclerosisBMJ198929866714052495042
  • SlemendaCWHuiSLLongcopeCJohnstonCCJrCigarette smoking, obesity, and bone massJ Bone Miner Res1989457377412816518
  • Ortego-CentenoNMunoz-TorresMHernandez-QueroJJurado-DuceAde la Higuera Torres-PucholJBone mineral density, sex steroids, and mineral metabolism in premenopausal smokersCalcif Tissue Int19945564034077895176
  • NutiRMartiniGMeasurements of bone mineral density by DXA total body absorptiometry in different skeletal sites in postmenopausal osteoporosisBone19921321731781576014
  • StaaTPLeufkensHCooperCThe epidemiology of corticosteroid-induced osteoporosis: a meta-analysisOsteoporos Int2002131077778712378366
  • CummingsSRNevittMCBrownerWSRisk factors for hip fracture in white womenN Engl J Med1995332127677747862179
  • Dargent-MolinaPSchottAHansDSeparate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS studyOsteoporos Int19999218819210367048
  • GarneroPHausherrEChapuyMCMarkers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective StudyJ Bone Miner Res19961110153115388889854
  • CummingsSRBrownerWSBauerDEndogenous hormones and the risk of hip and vertebral fractures among older womenN Engl J Med1998339117337389731089
  • NicholsGAGlauberHSBrownJBType 2 diabetes: incremental medical care costs during the 8 years preceding diagnosisDiabetes Care200023111654165911092288
  • ArredondoAZúnigaAEconomic consequences of epidemiological changes in diabetes in middle-income countriesDiabetes Care200427110410914693974
  • SeinoYIshidaHDiabetic osteopenia: pathophysiology and clinical aspectsDiabetes Metab Rev199511121357600905
  • McNairPBone mineral metabolism in human type 1 (insulin dependent) diabetes mellitusDan Med Bull19883521091213282809
  • WeinstockRGolandRShaneEClemensTLindsayRBilezikianJBone mineral density in women with type II diabetes mellitusJ Bone Miner Res198941971012718784
  • IsaiaGBodratoLCarlevattoVMussettaMSalamanoGMolinattiGOsteoporosis in type II diabetesActa Diabetol1987244305310
  • Barrett-ConnorEHolbrookTSex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitusJAMA199226823333333371453525
  • IshidaHSeinoYMatsukuraSIkedaMDiabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetesMetabolism19853497978014033421
  • De LeeuwIAbsRBone mass and bone density in maturity-type diabetics measured by the 125I photon-absorption techniqueDiabetes1977261211301135590637
  • MeemaHMeemaSThe relationship of diabetes mellitus and body weight to osteoporosis in elderly femalesCan Med Assoc J19679631321396017698
  • JohnstonCJrHuiSLongcopeCBone mass and sex steroid concentrations in postmenopausal Caucasian diabeticsMetabolism19853465445503999976
  • BauerDBrownerWCauleyJFactors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research GroupAnn Intern Med199311896576658460853
  • IsaiaGArdissonePDi StefanoMBone metabolism in type 2 diabetes mellitusActa Diabetol1999361353810436250
  • GiaccaAFassinaACaviezelFCattaneoACaldirolaGPozzaGBone mineral density in diabetes mellitusBone19889129363259888
  • TuominenJImpivaaraOPuukkaPRönnemaaTBone mineral density in patients with type 1 and type 2 diabetesDiabetes Care19992271196120010388989
  • SosaMDominguezMNavarroMBone mineral metabolism is normal in non-insulin-dependent diabetes mellitusJ Diabetes Complicat19961042012058835919
  • AL-ElqASadat-AliMDiabetes mellitus and male osteoporosis. Is there a relationship?Saudi Med J200627111729173317106551
  • IzaolaaMEscuderoeEHerreroseVEffects of dietary intake and life style on bone density in patients with diabetes mellitus type 2Ann Nutr Metab20044814114515133318
  • DeutschmannHWegerMWegerWKotankoPDeutschmannMSkrabalFSearch for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral densityJ Intern Med2002252538939712528756
  • LenchikLRegisterTHsuFAdiponectin as a novel determinant of bone mineral density and visceral fatBone200333464665114555270
  • van DaelePStolkRBurgerHBone density in non-insulin-dependent diabetes mellitus: the Rotterdam StudyAnn Intern Med199512264094147856988
  • ForsenLMeyerHMidthjellKEdnaTDiabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health SurveyDiabetologia199942892092510491750
  • KwonDKimJChungKLeeJKimSLeeHBone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitusJ Obstet Gynaecol Res19962221571628697346
  • HeathH3rdMeltonL3rdChuCDiabetes mellitus and risk of skeletal fractureN Engl J Med1980303105675707402221
  • SchwartzASellmeyerDEnsrudKOlder women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab2001861323811231974
  • OttenbacherKOstirGPeekMGoodwinJMarkidesKDiabetes mellitus as a risk factor for hip fracture in Mexican American older adultsJ Gerontol A Biol Sci Med Sci20025710M64865312242318
  • IversRCummingRMitchellPPedutoADiabetes and risk of fractureDiabetes Care20012471198120311423502
  • NicodemusKFolsomAType 1 and type 2 diabetes and incident hip fractures in postmenopausal womenDiabetes Care20012471192119711423501
  • HampsonGEvansCPetittRBone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitusDiabetologia19984111131413209833939
  • SeemanEOsteoporosis in men: epidemiology, pathophysiology, and treatment possibilitiesAm J Med1993955S2228
  • CenterJNguyenTSchneiderDSambrookPEismanJMortality after all major types of osteoporotic fracture in men and women: an observational studyLancet1999353915687888210093980
  • JacksonSTenenhouseARobertsonLVertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos)Osteoporos Int200011868068711095171
  • BurgerHVan DaelePGrashuisKVertebral deformities and functional impairment in men and womenJ Bone Miner Res19971211521579240738
  • TakizawaMSuzukiKMatsubayashiTIncreased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: possible involvement of accelerated polyol pathway in its pathogenesisDiabetes Res Clin Pract200882111912618774197
  • XuLChengMLiuXShanPGaoHBone mineral density and its related factors in elderly male Chinese patients with type 2 diabetesArch Med Res200738225926417227738
  • BridgesMMoochhalaSBarbourJKellyCInfluence of diabetes on peripheral bone mineral density in men: a controlled studyActa Diabetol2005422828615944841
  • NoedinBECNeedAGChattertonBEHorowitzMMorrisHAThe relative contributions of age and years since menopause to postmenopausal bone lossJ Clin Endocrinol Metab199070183882294140
  • HadjidakisDJKokkinakisEPSfakianakisMERaptisSABone density patterns after normal and premature menopauseMaturitas200344427928612697368
  • RiggsBLKhoslaSMeltonLJSex steroids and the construction and conservation of the adult skeletonEndocr Rev200223327930212050121
  • MoghimiNRahimiEDerakhshanSFarhadifarFOsteoporosis in postmenopausal diabetic women; prevalence and related factorsIran J Nucl Med20081622833
  • Al-MaatouqMAEl-DesoukiMIOthmanSAMattarEHBabayZAAddarMPrevalence of osteoporosis among postmenopausal females with diabetes mellitusSaudi Med J200425101423142715494815
  • AnaforogluINar-DemirerABascil-TutuncuNErtorerMPrevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetesJ Diabetes Complicat2009231121718413190
  • KrakauerJMcKennaMBudererNRaoDWhitehouseFParfittABone loss and bone turnover in diabetesDiabetes19954477757827789645
  • OkazakiRTotsukaYHamanoKMetabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnoverJ Clin Endocrinol Metab1997829291529209284719
  • HaffnerSBauerRThe association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal womenMetabolism19934267357388510518
  • ReidIEvansMCooperGAmesRStapletonJCirculating insulin levels are related to bone density in normal postmenopausal womenAm J Physiol Endocrinol Metab19932654E655
  • StolkRVan DaelePPolsHHyperinsulinemia and bone mineral density in an elderly population: the Rotterdam StudyBone19961865455498805995
  • Barrett-ConnorEKritz-SilversteinDDoes hyperinsulinemia preserve bone?Diabetes Care19961912138813928941469
  • MajimaTKomatsuYYamadaTDecreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patientsOsteoporos Int200516890791315558237
  • AkanumaYNon-insulin-dependent diabetes mellitus (NIDDM) in JapanDiabet Med1996139 Suppl 6S11128894473
  • YoshinagaHKosakaKHeterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesityDiabetes Res Clin Pract199944212913610414932
  • OzSGuvenGKilicarslanACalikNBeyazitYSozenTEvaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitusJ Natl Med Assoc200698101598160417052049
  • HawkerGJamalSRidoutRChaseCA clinical prediction rule to identify premenopausal women with low bone massOsteoporos Int200213540040612086351
  • HoAKungADeterminants of peak bone mineral density and bone area in young womenJ Bone Miner Metab200523647047516261454
  • EspallarguesMSampietro-ColomLEstradaMIdentifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literatureOsteoporos Int2001121081182211716183
  • VestergaardPDiscrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes – a meta-analysisOsteoporos Int200718442744417068657
  • WangMBachrachLVan LoanMHudesMFlegalKCrawfordPThe relative contributions of lean tissue mass and fat mass to bone density in young womenBone200537447448116040285
  • BarreraGBunoutDGattásVde la MazaMLeivaLHirschSA high body mass index protects against femoral neck osteoporosis in healthy elderly subjectsNutrition200420976977115325685
  • LauderdaleDRathouzPBody mass index in a US national sample of Asian Americans: effects of nativity, years since immigration and socioeconomic statusInt J Obes200024911881194
  • TorrénsJSkurnickJDavidowAEthnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetesDiabetes Care200427235436114747213
  • FordESWilliamsonDFLiuSWeight change and diabetes incidence: findings from a national cohort of US adultsAm J Epidemiol199714632142229247005
  • AsomaningKBertone-JohnsonERNascaPCHoovenFPekowPSThe association between body mass index and osteoporosis in patients referred for a bone mineral density examinationJ Womens Health (Larchmt)20061591028103417125421
  • HedleyAAOgdenCLJohnsonCLCarrollMDCurtinLRFlegalKMPrevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002JAMA2004291232847285015199035
  • OkosunISChoiSMatamorosTDeverGObesity is associated with reduced self-rated general health status: evidence from a representative sample of white, black, and Hispanic AmericansPrev Med200132542943611330993
  • FlegalKMCarrollMDOgdenCLJohnsonCLPrevalence and trends in obesity among US adults, 1999–2000JAMA2002288141723172712365955
  • BaltrusPTLynchJWEverson-RoseSRaghunathanTEKaplanGARace/ethnicity, life-course socioeconomic position, and body weight trajectories over 34 years: the Alameda County StudyAm J Public Health20059591595160116051936
  • HeXZBakerDWBody mass index, physical activity, and the risk of decline in overall health and physical functioning in late middle ageAm J Public Health20049491567157315333316
  • KahnHSWilliamsonDFIs race associated with weight change in US adults after adjustment for income, education, and marital factors?Am J Clin Nutr19915361566S1570S2031489
  • PaeratakulSLovejoyJRyanDBrayGThe relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adultsInt J Obes200226912051210
  • SeoDCTorabiMRRacial/ethnic differences in body mass index, morbidity and attitudes toward obesity among US adultsJ Natl Med Assoc20069881300130816916128
  • KuczmarskiRJFlegalKMCampbellSMJohnsonCLIncreasing prevalence of overweight among US adultsJAMA199427232052118022039
  • KoGChanJWooJSimple anthropometric indexes and cardiovascular risk factors in ChineseInt J Obes199721119951001
  • MillarWJStephensTThe prevalence of overweight and obesity in Britain, Canada, and United StatesAm J Public Health198777138413789235
  • ReederBAAngelALedouxMRabkinSWYoungTKSweetLObesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research GroupCMAJ199214611200920191596850
  • LeanMHanTMorrisonCWaist circumference as a measure for indicating need for weight managementBMJ199531169981581617613427
  • HsuYChenCFengFMajor determinants of bone mineral density (BMD) at multiple skeletal sites in ChineseJ Bone Miner Res200419S421
  • DeurenbergPYapMvan StaverenWABody mass index and percent body fat: a meta analysis among different ethnic groupsInt J Obes1998221211641171
  • NovotnyRDavisJRossPWasnichRAdiposity and blood pressure in a multiethnic population of women in HawaiiEthn Health1998331671739798115
  • RosenCJBouxseinMLMechanisms of disease: is osteoporosis the obesity of bone?Nat Clin Pract Rheumatol200621354316932650
  • WehrliFWHopkinsJAHwangSNSongHKSnyderPJHaddadJGCross-sectional study of osteopenia with quantitative MR imaging and bone densitometryRadiology2000217252753811058656
  • RishaugUBirkelandKFalchJVaalerSBone mass in non-insulin-dependent diabetes mellitusScand J Clin Lab Investig19955532572627638560
  • El MiedanyYEl GaafarySEl BaddiniMOsteoporosis in older adults with non-insulin-dependent diabetes mellitus: is it sex related?Clin Exp Rheumatol199917556156710544839
  • SahinGBağisSCimenOBOzişikSGülerHErdoğanCLumbar and femoral bone mineral density in type 2 Turkish diabetic patientsActa Medica (Hradec Kralove)200144414114311836850
  • SertMTetikerTKirimSSoyupakSCanataroğluAKoçakMType 2 diabetes mellitus and osteopenia: is there an association?Acta Diabetol200340210510812861410
  • StrotmeyerESCauleyJASchwartzAVDiabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: the Health, Aging, and Body Composition StudyJ Bone Miner Res20041971084109115176990
  • Pérez-CastrillónJDe LuisDMartín-EscuderoJAsensioTdel AmoRIzaolaONon-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factorsJ Diabetes Complicat200418631732115531180
  • DennisonESyddallHAihie SayerACraigheadSPhillipsDCooperCType 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance?Diabetologia200447111963196815565368
  • Hossein-NezhadALarijaniBPajouhiMAdibiHType 2 diabetes mellitus and the effects of lifestyle on bone mineral density in pre- and postmenopausal womenIran J Diabetes Lipid Dis2004311321
  • De LiefdeIVan der KliftMde LaetCvan DaelePHofmanAPolsHBone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam StudyOsteoporos Int200516121713172015940395
  • GerdhemPIsakssonAÅkessonKObrantKJIncreased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitusOsteoporos Int200516121506151215824889
  • SharifiFMoghaddamNAMousavi-NasabNThe effects of type ii diabetes on bone density in menopause womenIran J Diabetes Lipid Dis200552135142 Persian
  • MaghbooliZHossein-nezhadAKhoshniatMAdibiHMohammadzadehNLarijaniBA study of bone mineral density in diabetes mellitus patientsIran J Public Health20073744
  • BroussardDMagnusJInfluence of cardiovascular disease risk factors on the relationship between low bone mineral density and type 2 diabetes mellitus in a multiethnic US population of women and men: a cross-sectional studyGend Med20085322923818727989
  • Al-ZaabiKBadrHEMahussainSMohammadMAl-NafisiNBadrHESBone mass density in diabetic women: is there a detrimental effect?Middle East J Age Aging2008521217
  • HadzibegovicIMiskicBCosicVPrvulovicDBistrovicDIncreased bone mineral density in postmenopausal women with type 2 diabetes mellitusAnn Saudi Med200828210210418398285
  • HosodaHFukuiMNakayamaIBone mass and bone resorption in postmenopausal women with type 2 diabetes mellitusMetabolism200857794094518555835
  • GuptaRMohammedAMMojiminiyiOAAleniziEKAbdullaNABone mineral density in premenopausal Arab women with type 2 diabetes mellitusJ Clin Densitom2009121545719004653
  • ShanPWuXZhangHBone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland ChinaJ Bone Miner Metab200927219019719169767
  • ZhouYLiYZhangDWangJYangHPrevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetesDiabetes Res Clin Pract201090326126920950884